Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
- 1 June 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 114 (6) , 1188-1195
- https://doi.org/10.1016/s0016-5085(98)70424-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The significance of allelic deletions and aneuploidy in colorectal carcinomaCancer, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Allelic Loss of Chromosome 18q and Prognosis in Colorectal CancerNew England Journal of Medicine, 1994
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Survival and acquired genetic alterations in colorectal cancerGastroenterology, 1992
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Identification of a Chromosome 18q Gene that Is Altered in Colorectal CancersScience, 1990
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Allelotype of Colorectal CarcinomasScience, 1989